Among the serum biomarkers explored in gynecologic oncology, Cancer Antigen 125 (CA125) and Human Epididymis Protein 4 (HE4) have been extensively studied in epithelial ovarian cancer and endometrial cancer [7,8]. This evidence concerns the gene MUC16 and endometrial cancer.